China ranks third in global AI competitiveness index for life sciences
On Monday, Deep Knowledge Group published the Global AI Competitiveness Index for life sciences, placing China in third place with a score of 85.3. This score indicates the country's significant capabilities in AI, biotechnology, and talent, ranking behind only the US and UK, while surpassing Switzerland and Germany. The index assesses AI competitiveness at the national level. By 2030, China plans to implement AI-assisted diagnosis and treatment in primary healthcare facilities, aiming for nationwide AI-enabled healthcare. Additionally, Hong Kong secured third place among 20 city-level innovation hubs, following Boston and San Francisco, but ahead of London and New York City, thanks to its strengths in capital-market access and institutional credibility.
Key facts
- China ranked third in the Global AI Competitiveness Index for life sciences with a score of 85.3.
- The index was released on Monday by Deep Knowledge Group.
- China trails only the US and UK, and is ahead of Switzerland and Germany.
- The score reflects 'major scale in AI, biotechnology and talent'.
- China plans to deploy AI-assisted diagnosis and treatment in primary-level institutions by 2030.
- Hong Kong ranked third among 20 city-level innovation hubs, behind Boston and San Francisco.
- Hong Kong's strengths include capital-market access, institutional credibility, and interface with the Greater Bay Area.
- Hong Kong's 2025 Policy Address positions AI-enabled healthcare as part of a life-sciences infrastructure push.
Entities
Institutions
- Deep Knowledge Group
- Greater Bay Area
Locations
- China
- United States
- United Kingdom
- Switzerland
- Germany
- Hong Kong
- Boston
- San Francisco
- London
- New York City